$3.69
0.216.03%
At Close: -
$3.69
00.00%
After Hours: 6:37 PM EDT
15 minutes delayed
Comments
Loading...
Pyxis Oncology
PYXSNASDAQ
Pyxis Oncology (NASDAQ:PYXS) Stock, Insider Trading Activity
Pyxis Oncology: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Pyxis Oncology Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Pyxis Oncology Inc
Institutional Shares Held
5.207M
Institutional Percentage Held
8.84%
| Sep 28, 2023 | Pamela Connealy | CFO AND COO | 8.00K | $1.87 | $14.96K | BUY | 0.99% | 818.53K | Sep 28 | View |
| Sep 27, 2023 | Jitendra Wadhane | CHIEF ACCOUNTING OFFICER | 2.50K | $1.87 | $4.67K | BUY | 1.11% | 226.94K | Sep 27 | View |
| Sep 27, 2023 | Pamela Connealy | CFO AND COO | 6.43K | $1.85 | $11.87K | BUY | 0.80% | 810.53K | Sep 27 | View |
| Sep 25, 2023 | Jitendra Wadhane | CHIEF ACCOUNTING OFFICER | 5.00K | $1.77 | $8.85K | BUY | 2.28% | 224.44K | Sep 25 | View |
| Sep 25, 2023 | Pamela Connealy | CFO AND COO | 12.00K | $1.67 | $20.04K | BUY | 1.51% | 804.11K | Sep 25 | View |
| Sep 22, 2023 | Jitendra Wadhane | CHIEF ACCOUNTING OFFICER | 2.50K | $1.74 | $4.35K | BUY | 1.15% | 219.44K | Sep 22 | View |
| Sep 22, 2023 | Pamela Connealy | CFO AND COO | 5.00K | $1.74 | $8.70K | BUY | 0.64% | 792.11K | Sep 22 | View |
| Sep 18, 2023 | Lara Sullivan | PRESIDENT AND CEO | -8.64K | $2.10 | -$18.16K | SELL | -0.36% | 2.40M | Sep 14 - Sep 18 | View |
| Sep 13, 2023 | Lara Sullivan | PRESIDENT AND CEO | -212.66K | $2.15 | -$456.80K | SELL | -8.10% | 2.41M | Sep 11 - Sep 13 | View |
| Mar 21, 2023 | PFIZER INCPfizer Ventures US LLC | 10% OWNER | 1.81M | $2.76 | $5.00M | BUY | 34.70% | 7.03M | Mar 17 | View |
| Apr 25, 2022 | Mark Chin | — | -1.75M | $3.05 | -$5.32M | SELL | -100.00% | 0.00 | Apr 21 | View |
| Dec 09, 2021 | Darren S Cline | DIRECTOR | 10.00K | $9.39 | $93.89K | BUY | ∞ | 10.00K | Dec 08 | View |
| Nov 19, 2021 | Thomas Civik | DIRECTOR | 15.70K | $12.74 | $200.02K | BUY | ∞ | 15.70K | Nov 18 | View |
| Oct 15, 2021 | Mark Chin | — | 1.75M | $16.00 | $5.00M | BUY | ∞ | 1.75M | Oct 13 | View |
| Oct 15, 2021 | Cormorant Asset Management LPBihua ChenCormorant Global Healthcare Master Fund LPCormorant Private Healthcare Fund III LP | DIRECTOR | 1.12M | $16.00 | $7.20M | BUY | ∞ | 1.12M | Oct 13 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.